Difference between revisions of "Team:Tel-Hai"

 
(5 intermediate revisions by 2 users not shown)
Line 2: Line 2:
 
<img id="topimg" src="https://static.igem.org/mediawiki/2016/8/8b/T--Tel-Hai--dna.jpg" />
 
<img id="topimg" src="https://static.igem.org/mediawiki/2016/8/8b/T--Tel-Hai--dna.jpg" />
 
</html> {{Team:Tel-Hai/Header}} <html>
 
</html> {{Team:Tel-Hai/Header}} <html>
 +
<br>
 +
<br>
 +
<br>
 +
<br>
 +
<br>
 +
 +
 +
<p style="text-align: center; margin: 2em 0;">
 +
  <video src="https://static.igem.org/mediawiki/2016/7/79/T--Tel-Hai--video.mp4" style="max-width: 85%;" controls />
 +
</p>
  
 
<div class="space-equally">
 
<div class="space-equally">
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
   <div class="flipper"><div class="front">
 
   <div class="flipper"><div class="front">
       <h3><span>Where<span> is the magic happening?</h3>
+
       <h3><span>Where</span> is the magic happening?</h3>
 
     </div><div class="back">
 
     </div><div class="back">
 
       <p>Tel-Hai and MIGAL's labs located in northen Israel</h3>
 
       <p>Tel-Hai and MIGAL's labs located in northen Israel</h3>
Line 15: Line 25:
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
   <div class="flipper"><div class="front">
 
   <div class="flipper"><div class="front">
       <h3><span>Who<span> are we?</h3>
+
       <h3><span>Who</span> are we?</h3>
 
     </div><div class="back">
 
     </div><div class="back">
 
       <p>Group of dedicated students and researchers from the fields of biotechnology and biochemistry</p>
 
       <p>Group of dedicated students and researchers from the fields of biotechnology and biochemistry</p>
Line 24: Line 34:
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
   <div class="flipper"><div class="front">
 
   <div class="flipper"><div class="front">
       <h3><span>What<span> is our goal?</h3>
+
       <h3><span>What</span> is our goal?</h3>
 
     </div><div class="back">
 
     </div><div class="back">
 
       <p>Correcting the most prevalent mutation in the CFTR protein, causing Cystic Fibrosis, in somatic cells</p>
 
       <p>Correcting the most prevalent mutation in the CFTR protein, causing Cystic Fibrosis, in somatic cells</p>
Line 33: Line 43:
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
   <div class="flipper"><div class="front">
 
   <div class="flipper"><div class="front">
       <h3><span>Why<span> choose this?</h3>
+
       <h3><span>Why</span> did we choose Cystic Fibrosis?</h3>
 
     </div><div class="back">
 
     </div><div class="back">
       <p>This is a "simple" missense mutation, leading the to loss of single amino acid, causing Cystic Fibrosis - a largely researched lethal genetic disease, found in every ethnic group world-wide.</p>
+
       <p>This is a "simple" missense mutation, leading to the loss of single amino acid, causing Cystic Fibrosis - a largely researched lethal genetic disease, found in every ethnic group world-wide.</p>
 
     </div>
 
     </div>
 
</div></div>
 
</div></div>
Line 42: Line 52:
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
   <div class="flipper"><div class="front">
 
   <div class="flipper"><div class="front">
       <h3><span>Why now<span> of all times?</h3>
+
       <h3><span>Why now</span> of all times?</h3>
 
     </div><div class="back">
 
     </div><div class="back">
 
       <p>Only recently has genome editing become an affordable and practical tool for <strong>all researchers</strong>, to maximize efficiency in correcting diseases causing mutations.</p>
 
       <p>Only recently has genome editing become an affordable and practical tool for <strong>all researchers</strong>, to maximize efficiency in correcting diseases causing mutations.</p>
Line 51: Line 61:
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
<div class="flip-container" ontouchstart="this.classList.toggle('hover');">
 
   <div class="flipper"><div class="front">
 
   <div class="flipper"><div class="front">
       <h3><span>How<span>?</h3>
+
       <h3><span>How</span> can we do it?</h3>
 
     </div><div class="back">
 
     </div><div class="back">
 
       <p>Utilizing the Cholera toxin's non-toxic B Sub-unit as a delivery system for a plasmid containing a CRISPR/Cas9 apparatus, so as to specifically correct the defected DNA fragment with minimal collateral damage.</p>
 
       <p>Utilizing the Cholera toxin's non-toxic B Sub-unit as a delivery system for a plasmid containing a CRISPR/Cas9 apparatus, so as to specifically correct the defected DNA fragment with minimal collateral damage.</p>
Line 57: Line 67:
 
</div></div>
 
</div></div>
 
</div>
 
</div>
<p style="text-align: center; margin-top: 2em;">
+
 
  <video src="https://static.igem.org/mediawiki/2016/7/79/T--Tel-Hai--video.mp4" style="max-width: 85%;" controls />
+
</p>
+
  
 
</div></html>
 
</div></html>

Latest revision as of 22:30, 19 October 2016

iGEM Tel-Hai 2016






Where is the magic happening?

Tel-Hai and MIGAL's labs located in northen Israel

Who are we?

Group of dedicated students and researchers from the fields of biotechnology and biochemistry

What is our goal?

Correcting the most prevalent mutation in the CFTR protein, causing Cystic Fibrosis, in somatic cells

Why did we choose Cystic Fibrosis?

This is a "simple" missense mutation, leading to the loss of single amino acid, causing Cystic Fibrosis - a largely researched lethal genetic disease, found in every ethnic group world-wide.

Why now of all times?

Only recently has genome editing become an affordable and practical tool for all researchers, to maximize efficiency in correcting diseases causing mutations.

How can we do it?

Utilizing the Cholera toxin's non-toxic B Sub-unit as a delivery system for a plasmid containing a CRISPR/Cas9 apparatus, so as to specifically correct the defected DNA fragment with minimal collateral damage.